Project Grant HT9425261E257
- Grant Award Summary The University of Miami's Office of Research Administration received a $602,841 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective June 15, 2026, through June 14, 2030. The award supports research titled "Bringing Alzheimer's Detection to the Front Lines: Evaluating Novel Cognitive and Plasma Biomarkers in Primary Care," conducted at the University of Miami's facility in South Miami,...
- Federal Grant Award Summary The University of Miami's Office of Research Administration - School of Medicine received a $999,999 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded on June 1, 2026, with a completion date of May 31, 2029. This award supports the development of a Schwann cell-derived extracellular vesicle platform designed to advance biomarker discovery for amyotrophic lateral sclerosis (ALS) in...
- Federal Grant Award Summary The University of Miami, through its Office of Research Administration at the School of Medicine, received a $490,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2026 to June 30, 2028. The award supports research focused on elucidating metabolic-epigenetic rewiring in chordoma, a rare malignant tumor. This project contributes to the DHA's broader mission of...
- Federal Grant Award Summary The University of Florida's Division of Sponsored Research received a $996,586 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective May 15, 2025, through May 14, 2028. This three-year research initiative investigates alcohol use as a moderating factor in serotonergic neurodegeneration during the early stages of Alzheimer's disease. The award supports hypothesis-driven biomedical...
- Federal Grant Award Summary The University of Michigan received a $838,945 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2026, through June 30, 2028. The award supports research addressing TDP43-dependent disease mechanisms in amyotrophic lateral sclerosis (ALS) through selective pharmacological cochaperones. This research initiative will be conducted at the University of Michigan's Ann Arbor...
- This Project Grant award of $894,330.00 from the U.S. Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is funding research conducted by the University of Miami to investigate "Targeting Axonal Regeneration Pathways as a Therapeutic Approach to ALS." The project aims to transform healthcare for military service members and the broader public by advancing biomedical research into innovative medical solutions for critical health challenges. The award...
- The University of Miami has been awarded a $1,700,000.00 Project Grant from the Department of Defense (DoD) through the Military Medical Research and Development (CFDA 12.420) federal grant program. This grant will support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The research funded under this 2-year grant, with a performance period from September 15, 2024 to September 14, 2026, will explore innovative...
- Federal Project Grant Award Summary The Trustees of Indiana University received a $999,949 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded on September 30, 2026, with a completion date of September 29, 2029. The grant funds a prospective longitudinal research study examining the relationship between social networks, brain health, and cognitive function in current and former warfighters, with particular focus on...
- Federal Grant Award Summary The University of Michigan's Office of Research and Sponsored Projects received a $248,156 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period October 1, 2025 through September 30, 2027. The award supports research focused on identifying molecular biomarkers for invasive glioblastoma cell states and tumor microenvironment modulation. This research initiative will be conducted at...
- This Project Grant award, totaling $1,535,000.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Miami. The award will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the research will target the reflux-activated oncogenic mRNA translation program in esophageal adenocarcinoma, with a performance period from...
The University of Miami's Office of Research Administration received a $1,092,670 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on June 15, 2026, with a completion date of June 14, 2030. The award funds research titled "Bringing Alzheimer's Detection to the Front Lines: Evaluating Novel Cognitive and Plasma Biomarkers in Primary Care," conducted at the institution's South Miami, Florida campus. This research initiative focuses on advancing early detection and diagnosis of Alzheimer's disease through the evaluation of innovative biomarkers suitable for implementation in primary care settings, with particular relevance to military service members and veterans. Under the DHA's Military Medical Research and Development program, the University of Miami will deliver translational research and biomarker discovery services designed to transform healthcare through innovative medical solutions. The project represents the program's emphasis on hypothesis-driven research addressing critical health challenges, including neurodegenerative diseases. As a four-year award, the research will generate evidence and methodologies to facilitate earlier Alzheimer's detection in frontline clinical environments, supporting the broader military health mission of improving healthcare outcomes for service members and the American public.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.1m | 6/4/26 |